Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Binh Dinh Pharmaceutical And Medical Equipment JSC's quarterly Ending Cash Position
declined
from Sep. 2025 (₫219,991 Mil) to Dec. 2025 (₫202,784 Mil) and
declined
from Dec. 2025 (₫202,784 Mil) to Mar. 2026 (₫121,474 Mil).
Binh Dinh Pharmaceutical And Medical Equipment JSC's annual Ending Cash Position
increased
from Dec. 2023 (₫87,837 Mil) to Dec. 2024 (₫314,199 Mil) but then
declined
from Dec. 2024 (₫314,199 Mil) to Dec. 2025 (₫202,784 Mil).
Binh Dinh Pharmaceutical And Medical Equipment JSC Ending Cash Position Related Terms
Binh Dinh Pharmaceutical And Medical Equipment JSC Ending Cash Position Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC Ending Cash Position Chart
Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
Binh Dinh Pharmaceutical And Medical Equipment JSC Ending Cash Position Calculation
Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.
What does a Ending Cash Position of ₫121,474 Mil mean?
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a Ending Cash Position of ₫121,474 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's Ending Cash Position too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current Ending Cash Position is ₫121,474 Mil. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's Ending Cash Position compare to ZTS and UTHR?
Binh Dinh Pharmaceutical And Medical Equipment JSC's Ending Cash Position of ₫121,474 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. Binh Dinh Pharmaceutical And Medical Equipment JSC's current Ending Cash Position is ₫121,474 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,501.70, compared to a current price of ₫49,900.00 — trading 5% below its estimated fair value. The current Ending Cash Position is ₫121,474 Mil. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current Ending Cash Position is ₫121,474 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be undervalued.
The current stock price of ₫49,900.00 is trading 5% below its estimated GF Value™ of ₫52,501.70.
GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
Ending Cash Position: ₫121,474 Mil
GF Value™: ₫52,501.70 vs. price of ₫49,900.00 (5% below fair value)
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
82GF Score
Get the complete analysis for STC:DBD
Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DBD has been successfully added to your 
